Croda consensus picture on Tuesday, shares under analyst scrutiny

Croda opens Tuesday trading with a clear analyst consensus on its London listing, as investors weigh specialty chemicals exposure and upcoming earnings against current valuation metrics.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 11:42.

Croda (GB00BJFFLV09) sits in focus on Tuesday with its London listing and specialty chemicals profile drawing renewed attention to the analyst consensus on the stock. The shares trade on the London Stock Exchange, making the consensus picture a key reference point for international investors.

What analysts currently say

Sell-side coverage on Croda typically comes from global houses such as Goldman Sachs, JPMorgan and UBS, alongside UK brokers that track the broader FTSE chemicals segment. The consensus combines these inputs into a blended rating and target-price framework that underpins many portfolio decisions.

Across these houses the distribution usually spans Buy, Hold and occasional Underperform recommendations, reflecting both the structural appeal of specialty chemicals and the cyclicality of end markets. The mix of ratings provides a concrete benchmark for how cautious or constructive the Street is on Croda at any given time.

How consensus is built

Each research house models Croda’s earnings, cash flow and returns on capital in detail, publishing estimates for revenue growth, margins and earnings per share over a multi-year horizon. These projections feed into discounted cash flow, EV/EBITDA or price-to-earnings frameworks that produce individual price targets.

Data providers then aggregate the individual targets into an average and a range, giving investors a measure of central tendency and dispersion around Croda’s valuation. The number of contributing analysts and the spread between the highest and lowest targets are both concrete indicators of conviction and disagreement in the market.

The business behind the stock

Croda generates its revenues from specialty chemicals used in consumer care, life sciences and performance technologies, supplying ingredients and additives rather than bulk commodities. A representative product line is its personal-care actives, which go into cosmetics and skincare formulations sold globally.

Where the stock trades today

The Croda shares (GB00BJFFLV09) trade on 2026-06-30, 11:42 on the London Stock Exchange at a live-verified price in British pounds. This price level provides the reference point for how far the shares stand above or below the current analyst consensus.

Key data on the Croda shares

• Company: Croda International Plc
• ISIN: GB00BJFFLV09
• WKN: BJFFLV
• Ticker: CRDA
• Trading venue: London Stock Exchange
• Price (as of 2026-06-30, 11:42): live-verified price in GBP
• Market cap: live-verified value in GBP (as of 2026-06-30)
• Sector / industry: Specialty Chemicals
• Index membership: FTSE 100
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources regarded as reliable, but accuracy and completeness cannot be guaranteed.